Vimarsana
Biggest News Aggregation in the World

Page 7 - John Quisel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Quisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Quisel Today - Breaking & Trending Today

Disc Medicine Initiates BEACON, a Phase 2 Clinical Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP) - Vimarsana News

Disc Medicine Initiates BEACON, a Phase 2 Clinical Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP)

/PRNewswire/ -- Disc Medicine, a clinical-stage biotechnology company dedicated to the discovery and development of novel therapeutic candidates for the...

Gemini Therapeutics and Disc Medicine Announce Merger Agreement - Vimarsana News

Gemini Therapeutics and Disc Medicine Announce Merger Agreement

10.08.2022 - Gemini Therapeutics, Inc. (Nasdaq: GMTX) (“Gemini”) and Disc Medicine, Inc. (“Disc”), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious ... Seite 1

Gemini stock soars 35% on merger with Disc Medicine in all-stock deal - Vimarsana News

Gemini stock soars 35% on merger with Disc Medicine in all-stock deal

Gemini Therapeutics (GMTX) is merging with privately held Disc Medicine in an all-stock transaction.The combined company — which will be headquarters in Watertown, Massachusetts — will...

Gemini's fall gives Disc a way around biotech's IPO slump - Vimarsana News

Gemini's fall gives Disc a way around biotech's IPO slump

BioPharma

Disc Medicine Initiates Phase 1b/2 Clinical Study of DISC-0974 in Myelofibrosis Patients with Severe Anemia - Vimarsana News

Disc Medicine Initiates Phase 1b/2 Clinical Study of DISC-0974 in Myelofibrosis Patients with Severe Anemia

Open-label study will evaluate the potential for DISC-0974, a first-in-class, anti-HJV (hemojuvelin) monoclonal antibody to improve anemia in myel...